Witczak, C. A., and M. Sturek. Exercise prevents diabetesinduced impairment in superficial buffer barrier in porcine coronary smooth muscle. J Appl Physiol 96: 1069-1079, 2004. First published November 21, 2003 10.1152/japplphysiol.00460.2003.-In healthy coronary smooth muscle cells, the superficial sarcoplasmic reticulum (SR) buffers rise in intracellular Ca 2ϩ levels. In diabetic dyslipidemia, basal Ca 2ϩ levels are increased, yet Ca 2ϩ influx is decreased and SR Ca 2ϩ uptake is increased. Exercise prevents diabetic dyslipidemiainduced increases in basal Ca 2ϩ levels and decreases in Ca 2ϩ influx. We tested the hypothesis that diabetic dyslipidemia impairs Ca 2ϩ extrusion via a decrease in superficial SR and that exercise will prevent these losses. Male Yucatan swine were maintained in four treatment groups: control, hyperlipidemic, diabetic dyslipidemic, and diabetic dyslipidemic plus aerobically exercise trained. Intracellular Ca 2ϩ levels were measured during depolarization-induced Ca 2ϩ influx and caffeine-induced SR Ca 2ϩ release. Na ϩ /Ca 2ϩ exchanger and plasmalemmal Ca 2ϩ -ATPase activity were assessed by inhibition with low extracellular Na ϩ and 5,6-carboxyeosin, respectively. Superficial SR was quantified using the internal membrane dye 3,3Ј-dihexyloxacarbocyanine iodide (DiOC6) and novel analysis techniques. We found that, in diabetic dyslipidemia, Ca 2ϩ extrusion was impaired and superficial SR was decreased. Exercise prevented the diabetic dyslipidemia-induced decrease in superficial SR and restored plasmalemmal Ca 2ϩ extrusion. On the basis of these results, we conclude exercise attenuates the diabetic dyslipidemia-induced impairment in intracellular Ca 2ϩ regulation.
In diabetic dyslipidemia, basal Ca 2ϩ levels are increased, yet Ca 2ϩ influx is decreased and SR Ca 2ϩ uptake is increased. Exercise prevents diabetic dyslipidemiainduced increases in basal Ca 2ϩ levels and decreases in Ca 2ϩ influx. We tested the hypothesis that diabetic dyslipidemia impairs Ca 2ϩ extrusion via a decrease in superficial SR and that exercise will prevent these losses. Male Yucatan swine were maintained in four treatment groups: control, hyperlipidemic, diabetic dyslipidemic, and diabetic dyslipidemic plus aerobically exercise trained. Intracellular Ca 2ϩ levels were measured during depolarization-induced Ca 2ϩ influx and caffeine-induced SR Ca 2ϩ release. Na ϩ /Ca 2ϩ exchanger and plasmalemmal Ca 2ϩ -ATPase activity were assessed by inhibition with low extracellular Na ϩ and 5,6-carboxyeosin, respectively. Superficial SR was quantified using the internal membrane dye 3,3Ј-dihexyloxacarbocyanine iodide (DiOC6) and novel analysis techniques. We found that, in diabetic dyslipidemia, Ca 2ϩ extrusion was impaired and superficial SR was decreased. Exercise prevented the diabetic dyslipidemia-induced decrease in superficial SR and restored plasmalemmal Ca 2ϩ extrusion. On the basis of these results, we conclude exercise attenuates the diabetic dyslipidemia-induced impairment in intracellular Ca 2ϩ regulation.
sodium-calcium exchanger; plasma membrane calcium-adenosinetriphosphatase; sarco(endo)plasmic reticulum calcium-transporting adenosinetriphosphatase DIABETES CURRENTLY AFFLICTS over 16,000,000 Americans (25) , creating a total economic burden of over one hundred billion dollars ($100,000,000,000) in medical costs (2) . With epidemiological estimates projecting the number of individuals with diabetes to reach almost 22,000,000 by the year 2025 (22) , diabetes is rapidly being recognized as a public health threat that is rising to epidemic proportions. Coronary artery disease is increased three-to sixfold in diabetes (45) and represents the leading cause of death in diabetic patients (22) . It has been proposed that impaired intracellular Ca 2ϩ regulation underlies the increase in coronary artery disease seen in diabetic dyslipidemia (24) .
In healthy coronary smooth muscle cells, intracellular Ca 2ϩ levels are regulated by both the structural localization of the sarcoplasmic reticulum (SR) as well as the functional activity of the intracellular Ca 2ϩ transporters. According to the superficial buffer barrier hypothesis, the superficial SR buffers rises in steady-state intracellular Ca 2ϩ levels because of the sequestration of subplasmalemmal Ca 2ϩ as well as the directed release of SR Ca 2ϩ toward the plasmalemma (6, 7, 21) . Thus the superficial SR provides the structural framework for the functional coupling of Ca 2ϩ influx with both SR Ca 2ϩ -uptake and plasmalemmal Ca 2ϩ extrusion mechanisms [i.e., the Na ϩ / Ca 2ϩ exchanger (NCX) and the plasmalemmal Ca 2ϩ -ATPase (PMCA)]. In coronary smooth muscle cells from diabetic dyslipidemic swine, basal or steady-state intracellular Ca 2ϩ levels are increased (44) , yet Ca 2ϩ influx is decreased (40) and sarco(endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA) activity is increased (17) . These results suggest that plasmalemmal Ca 2ϩ extrusion is impaired in diabetic dyslipidemia. Disruption of the intracellular cytoskeleton and the endoplasmic reticulum has been shown to impair intracellular Ca 2ϩ regulation (13, 42) . In cultured, porcine coronary endothelial cells, retraction of the superficial endoplasmic reticulum with nocodazole uncoupled endoplasmic reticulum Ca 2ϩ release to NCX activity and resulted in a prolonged recovery of intracellular Ca 2ϩ levels after bradykinin stimulation (13) . Despite these significant findings on the relationship between impaired intracellular Ca 2ϩ regulation and superficial SR structure, no studies have investigated the relationship between the diabetic dyslipidemia-induced impairment in intracellular Ca 2ϩ regulation and structural alterations in the superficial SR in coronary smooth muscle.
Exercise training attenuates the progression of coronary artery disease and has been shown to elicit alterations in coronary smooth muscle intracellular Ca 2ϩ regulation. These include increases in Ca 2ϩ influx (5, 15) , increases in SR Ca 2ϩ unloading (i.e., directed release of SR Ca 2ϩ towards the plasmalemma at rest) (34) , and decreases in nuclear Ca 2ϩ signaling (39) . Because the SR has a finite capacity to store Ca 2ϩ , these results collectively suggest that exercise training enhances plasmalemmal Ca 2ϩ extrusion. Studies conducted by Heaps et al. (15) have demonstrated that the exercise-induced increase in Ca 2ϩ influx in coronary smooth muscle is not compensated by increases in plasmalemmal Ca 2ϩ extrusion via the NCX, suggesting that exercise enhances plasmalemmal Ca 2ϩ extrusion via the PMCA. However, to date there have been no studies that have directly examined PMCA activity in coronary smooth muscle with exercise training.
Exercise training has been demonstrated to prevent phenotypic changes in smooth muscle in response to organ culturing of coronary artery with the potent mitogen, endothelin-1 (39) . These changes included a decrease in total cellular DNA content that was observed concurrently with attenuated rises in nuclear Ca 2ϩ levels (39) . Furthermore, the organ culture model of coronary disease elicits significant changes in cellular morphology and decreased transnuclear SR distribution, i.e., altered deep SR (18) . The clear precedence for changes in SR morphology being associated with altered Ca 2ϩ homeostasis provides a rational basis for hypothesizing that alterations in superficial SR structure will be associated with altered Ca 2ϩ homeostasis, specifically Ca 2ϩ extrusion in diabetic dyslipidemia and exercise training.
Presently, to our knowledge, there are no reports demonstrating the protective effects of exercise on diabetic dyslipidemia-induced impairments in coronary smooth muscle intracellular Ca 2ϩ regulation. This void of information of cellular mechanisms exists, even though exercise is recommended for the reduction of lipid abnormalities and the prevention of coronary artery disease in individuals with diabetes (14, 27) . Thus we tested the hypotheses that the elevated basal intracellular Ca 2ϩ levels seen in cells from diabetic dyslipidemic swine were due to either 1) an impairment in plasmalemmal Ca 2ϩ extrusion and/or 2) a decrease in the amount of superficial SR and that 3) exercise training would prevent the impairment in steady-state intracellular Ca 2ϩ regulation by attenuating and/or preventing these alterations.
MATERIALS AND METHODS

Porcine Model of Cardiovascular Disease and Diabetes
All procedures involving animals were approved by the Animal Care and Use Committee of the University of Missouri and fully complied with the American Veterinary Medical Association Panel on Euthanasia. Male Yucatan swine (aged 8-15 mo) were obtained from the Sinclair Research Center (Columbia, MO) and randomly assigned to one of four treatment groups. These groups included 1) low-fat fed, sedentary (control; n ϭ 8); 2) high-fat-, high-cholesterol fed, sedentary (hyperlipidemic; n ϭ 7); 3) alloxan-induced hyperglycemic, high-fat, high-cholesterol fed, sedentary (diabetic dyslipidemic; n ϭ 7); and 4) diabetic dyslipidemic that were aerobically exercise trained (n ϭ 7). The low-fat diet consisted of Purina Minipig chow (Purina Mills, St. Louis, MO). Low-fat-fed animals were maintained at a weight gain of ϳ1.0% gain/wk by 1,050 g (3,182 kcal) of chow ration daily. The high-fat, high-cholesterol diet consisted of 1,000 g (3,957 kcal) Purina Minipig chow supplemented with 14.0 g cholesterol, 119.7 g coconut oil, 16.1 g corn oil, 4.9 g sodium cholate, and 241.8 g of sucrose. High-fat-, high-cholesterol-fed animals were maintained at a 3% weight gain/wk with additional feed as necessary to maintain the expected weight gain as described in detail (4). All animals were fed once daily and given free access to water.
Hyperglycemia was induced by the intravenous administration of 100 mg/kg of the pancreatic ␤ cell toxin, alloxan (9, 16) . Diabetic pigs were maintained with plasma glucose levels at 300-400 mg/dl for the duration of the study by using feed and insulin therapy algorithms that maintained a positive energy balance (body weight) and hyperglycemia (4) .
Exercise training consisted of treadmill running performed 4 days/wk for 20 wk. The training bout consisted of three stages: 1) a gradual 10-min warm-up, 2) 30-min at 65-75% of maximum heart rate (considered moderate intensity), and 3) a 5-min cool-down. Throughout the 20-wk training period, treadmill grade was increased to elicit the target heart rate range. At week 20, the animals were placed in a low-stress sling and attached to a heart rate monitor. After a 10-min acclimation period, 8-10 heart rate values were taken during a 10-min recording phase. These 8-10 values were averaged together to determine the resting heart rate for each animal. The animals did not exercise for 2 days before death to separate the acute effects of exercise from the chronic effects of training.
Fasting arterial blood samples were obtained from anesthetized animals at the time of death. Plasma was assayed for blood glucose levels by using standard methods by the Veterinary Clinical Pathology department at the University of Missouri (Columbia, MO). Plasma was directly assayed for total cholesterol and triglyceride levels by using a standard enzymatic kit (Sigma-Aldrich, St. Louis, MO) (9, 41) . Postprandial plasma lipid levels were assessed at week 12 of the experimental treatment. Arterial samples were obtained from fully conscious animals at 2 and 7 h after feed consumption. Plasma was directly assayed for total cholesterol and triglyceride levels using a standard enzymatic kit (Sigma-Aldrich) (9, 41) . After 20 wk in a treatment group, animals were anesthetized with isoflurane and the heart surgically removed. The right coronary artery was dissected away from the myocardium and placed in ice-cold Eagle's minimal essential storage media until ready for the isolation of smooth muscle cells.
Isolation of Coronary Smooth Muscle Cells
The procedure for the enzymatic dispersal of porcine coronary smooth muscle cells from arterial segments has been previously described (16, 17, 34) . Briefly, arterial sections were incubated with a collagenase solution containing 294 U/ml collagenase, 5 U/ml elastase, 2 mg/ml bovine serum albumin, 1 mg/ml soybean trypsin inhibitor, and 0.4 mg/ml DNase I. Cells were enzymatically dispersed by incubation in a shaking water bath at 37°C for 60 min. The first fraction, consisting largely of endothelial cells, was removed and discarded. Additional collagenase solution was added, and the cells incubated in the water bath for 30 min. Smooth muscle cells from this fraction were identified morphologically (38) and studied within 6 h of dispersion. These acutely used smooth muscle cells were not cultured in monolayer preparations.
Solutions
The physiological salt solution (PSS) contained (in mM) 138 NaCl, 5 KCl, 2 CaCl 2, 1 MgCl2, 10 HEPES, and 10 glucose, which was titrated to a pH of 7.4 with NaOH. The high-K ϩ solution (80K) contained (in mM) 65 NaCl, 80 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, and 10 glucose, which was titrated to a pH of 7.4 with NaOH. The high-K ϩ , low-Na ϩ solution (80Kϩ5Na) contained (in mM) 80 KCl, 2 CaCl2, 63 LiCl, 1 MgCl2, 10 HEPES, and 10 glucose, which was titrated to a pH of 7.4 with NaOH. Caffeine (Caf; Sigma-Aldrich) was directly dissolved into the high-K ϩ -containing solutions to a 5 mM final concentration. Stock solutions of thapsigargin (TG: SigmaAldrich) and 5,6-carboxyeosin (CBE; Sigma-Aldrich) were prepared in ethanol and dimethyl sulfoxide, respectively. Stock solutions of TG and CBE were diluted in high-K ϩ -containing solutions to final concentrations of 1 and 5 M, respectively.
Free Intracellular Ca 2ϩ Indicator, Fura-2
Basal intracellular free Ca 2ϩ levels were assessed using the fluorescent Ca 2ϩ indicator, fura-2 (Molecular Probes, Eugene, OR) to compare basal intracellular Ca 2ϩ levels with previous studies performed in this laboratory (16, 17, 34, 44) . Briefly, freshly dispersed cells were incubated with 2.5 M of fura-2 for 20 min in a shaking water bath at 37°C. Fura-2 was alternatively excited by 340 and 380 nm light every 0.20 s, and the emitted light was collected at 510 nm. The measurement of intracellular Ca 2ϩ levels was made by digital imaging epifluorescence microscopy and assessed as the emission of the fura-2 (340/380 nm) ratio.
Free Intracellular Ca 2ϩ Indicator, Fura Red
Changes in steady-state intracellular Ca 2ϩ levels were assessed by using the fluorescent Ca 2ϩ indicator, fura red (Molecular Probes).
Acutely dispersed cells were incubated with 5.0 M of fura red for 45 min in a shaking water bath at 37°C. Fura red was excited with 440-and 485-nm light image pairs collected every 10 s with digital imaging epifluorescence microscopy. Images were analyzed offline by using Image Pro Plus (4.0) software. With the use of Image Pro Plus, an area of interest was drawn around the cell edge. This area of interest was then applied to images acquired throughout the experimental protocol, and the mean pixel intensity was determined for each cell throughout the experiment. All cells were depolarized with high K ϩ to induce Ca 2ϩ influx. The SR Ca 2ϩ store was depleted with 5 mM caffeine. The SERCA, NCX, and PMCA were inhibited by 1 M TG, 5 mM extracellular Na ϩ , and 5 M CBE, respectively.
PMCA Inhibitor, CBE
Specificity for the PMCA. Laser scanning confocal microscopy was used to assess the specificity of CBE for the PMCA. Freshly dispersed cells were superfused with 5 M CBE for 3 min, and the localization of CBE within the cell was observed by using a Noran Oz laser scanning confocal microscope (39, 41) . After a thorough wash in PSS for 5 min, the cells were superfused with 2.5 ϫ 10 Ϫ7 M of the internal membrane dye, 3,3Ј-dihexyloxacarbocyanine iodide (DiOC 6; Molecular Probes) for 5 min. Visualization of both the CBE and the DiOC6 staining occurred via excitation using the 488-m line of an argonkrypton laser, and the emission was collected after passage through a 500-nm-long-pass filter. The nucleus was visualized using the fluorescent probe SYTO-64 (Molecular Probes). The SYTO64 (500 nM) was superfused over the cells for 5 min and then excited by using the 568-nm line of the argon-krypton laser. (For simplicity, the labeling of the nucleus with SYTO-64 is not shown.)
Delayed onset of PMCA inhibition. Digital imaging epifluorescence microscopy was used to assess the duration of time needed for CBE to bind the PMCA and inhibit its activity. Freshly dispersed cells loaded with fura red were superfused with PSS for 4 min and then exposed to one of four experimental solutions for 6 min. The composition of the experimental solutions was as follows: S1 ϭ 80KϩCafϩTG, S2 ϭ 80KϩCafϩTGϩ5Na, S3 ϭ 80KϩCafϩTGϩ CBE, and S4 ϭ 80KϩCafϩTGϩ5NaϩCBE. The kinetics of the intracellular Ca 2ϩ response was determined from the peak of the high-K ϩ /caffeine-induced response to 7 min from the start of the experiment and then from 7 to 10 min from the start of the experiment.
Quantification of Superficial SR by Using DiOC6
The fluorescent dyes utilized for the visualization of the superficial SR and the plasmalemma were DiOC 6 and 5-(and-6)-carboxyseminaphthorhodofluor (SNARF)-1 acetoxymethyl ester, acetate (SNARF; Molecular Probes), respectively. Freshly dispersed cells were incubated with 2.5 ϫ 10 Ϫ7 M DiOC6 for 30 min, washed in PSS, and incubated with 5.0 ϫ 10 Ϫ6 M SNARF for 30 min. Visualization of the dyes was performed by digital imaging epifluorescence microscopy. The DiOC 6 and SNARF were excited at 485 and 575 nm, respectively, and the emission was collected through a band-pass filter centered at 528 and 630 nm, respectively. Three images were acquired for each wavelength at z-axis intervals of 0.3 m. The focal plane of the DiOC 6 fluorescence was utilized as the midpoint of the cell. On the basis of spatial calibrations previously performed in the laboratory, these specifications allowed us to accurately measure intracellular distances down to ϳ154 nm. Acquired images were deconvolved by using Image Pro Plus (4.0) software to eliminate out-of-focus fluorescence (18) . The digital images were converted into numerical pixel intensity values using the Image Pro Plus Bit-Map Analysis function and then exported into Microsoft Excel spreadsheets. The intensity of the DiOC 6 fluorescence was normalized to the fluorescence of a 4-m multispectral bead (Molecular Probes) that was excited at 485 nm. The amount of superficial SR was calculated as the ratio of cell layer (average DiOC 6 intensity per area) to the bead (average fluorescence per area).
Statistical Analysis
The results are presented as the average of every cell ϮSE. Animal and cell numbers for groups in each experiment are indicated in the figure legends as n ϭ animal number/cell number. Statistical significance among treatment groups was defined as P Ͻ 0.05 and determined by the one-way analysis of variance test. Significance between individual groups was assessed by Student-Newman-Keuls post hoc analysis.
RESULTS
Basic Information on the Methodology
PMCA inhibitor, CBE. SPECIFICITY FOR THE PMCA. The specificity of CBE for the PMCA was assessed by laser confocal microscopy. The internal membrane dye, DiOC 6 , was utilized to assess the location of the SR. As shown in Figure 1A , the DiOC 6 fluorescence is primarily localized centrally within the cell. Figure 1B demonstrates the binding of CBE to both intracellular and plasmalemmal constituents. As shown in Fig.  1 , C-E, in which overlaps of both the CBE and DiOC 6 fluorescence are depicted, CBE does not bind selectively to the PMCA on the plasmalemma but also binds to constituents located on the SR (depicted by the yellow areas). The intense CBE fluorescence in the central portion of the cell denotes binding to the perinuclear SR, as previously described (12, 18, 39, 41) .
DELAYED ONSET OF PMCA INHIBITION. The kinetics of the intracellular Ca 2ϩ response with application of the inhibitors was assessed to determine the relative rate of inhibitor onset in cells isolated from control, hyperlipidemic, diabetic dyslipidemic, and diabetic dyslipidemic plus exercise-trained swine. For simplicity, typical tracings of the experimental protocols and kinetic measurements are only shown for cells from both the control (Fig. 2, A-D ) and diabetic dyslipidemic (Fig. 2, E-H) swine. The proteins inhibited by each of the experimental solutions is shown at the bottom of Fig. 2 . As depicted in Fig.  2 , A and E, all of the experimental solutions elicited an initial rise in intracellular Ca 2ϩ levels due to the depolarizationinduced opening of the voltage-gated Ca 2ϩ -channels and the depletion of the SR Ca 2ϩ store by high K ϩ and caffeine, respectively. However, with solutions S3 and S4, this rise in intracellular Ca 2ϩ levels was followed by a biphasic response in the fura red ratio. This included an initial decline in intracellular Ca 2ϩ levels from the peak response to ϳ7 min after solution exposure, followed by a subsequent rise in the intracellular Ca 2ϩ levels to the end of the experimental protocol. This secondary rise is likely due to the delayed onset of PMCA inhibition by CBE. Evidence to support this hypothesis is shown for control cells in Fig. 2 , B-D, in which the rates of the biphasic responses are compared for each of the experimental protocols. As shown in Fig. 2C , in healthy control cells, the initial rate of decline was not significantly different between solutions S1 and S3, or between S2 and S4, suggesting that the CBE was not yet inhibiting the PMCA. However, during the secondary phase of the response, the solutions containing CBE displayed a significant change in the rate of response relative to their non-CBE-containing counterparts (Fig. 2D, S3 and S4 ). Because previous experiments had already shown that 5 M CBE would not emit enough light to confound the Ca 2ϩ signal, this rise in intracellular Ca 2ϩ levels is likely due to the initiation of PMCA inhibition. The cellular response from the diabetic dyslipidemic swine was generally the same as those seen in the healthy cells. For example, all cells in both groups showed similar kinetic responses (i.e., an increase in intracellular Ca 2ϩ levels) with the application of high K ϩ and caffeine. Also, significant increases in the rate from 7 to 10 min were seen only in S3 and S4 (Fig. 2, D and H) . On the basis of these observations, it is not likely that the diabetic dyslipidemic condition affected the ability of this maximal concentration of CBE to inhibit the PMCA.
Given the slow rate of PMCA inhibition by CBE, kinetic measurements of the decline in the depolarization-and caffeine-induced Ca 2ϩ peak would not provide an accurate assessment of the functional capability of the intracellular Ca 2ϩ transporters. Thus the effectiveness of the NCX and the PMCA to alter steady state intracellular Ca 2ϩ levels was assessed as the change in the fura red ratio from the initial steady-state intracellular Ca 2ϩ level to the final steady-state level after experimental perturbation shown in Fig. 2 at 10 min. Steadystate measures were considered of most relevance because a major aim of this study was to determine the Ca 2ϩ extrusion mechanism involved in the regulation of basal (steady state) Ca 2ϩ levels. Quantification of superficial SR by using DiOC 6 . Quantification of the superficial SR was performed using the fluorescent dyes DiOC 6 and SNARF and novel analysis techniques. As shown in Fig. 3A , which represents the transmitted light image of a cell isolated from a control animal, only smooth muscle cells were selected for imaging on the basis of their morphological identification as smooth muscle cells. Visible movement in response to the superfusion with PSS was the only other criteria utilized for cell selection to prevent bias in the selection of specific populations of cells on the basis of morphology. Visualization of the dyes was performed by digital imaging epifluorescence microscopy. As stated previously, DiOC 6 is a fluorescent, lipophilic dye that stains internal membranes such as the SR and the Golgi apparatus (18) . In  Fig. 3B , the typical reticular pattern of the DiOC 6 staining is shown centrally in the cell with small punctuate "hot spots" denoting superficial SR located more peripherally as shown by the box in Fig. 3D . Figure 3C depicts the typical intracellular staining of SNARF. Although SNARF is a pH indicator, we found it to be a nearly ideal plasmalemmal marker because of its homogeneous distribution in the myoplasm, and its spectral properties yielded no overlap of fluorescence signals with DiOC 6 . Thus, as shown in Fig. 3D , the use of SNARF as a plasmalemmal marker enabled the identification of the plasmalemmal edge (shown in red) in the DiOC 6 -stained images. The digital images were converted into numerical pixel intensity values using the Image Pro Plus Bit-Map Analysis function as exported in Microsoft Excel worksheets as shown in Fig. 3E . With the use of the SNARF image to denote the plasmalemmal edge, only the DiOC 6 values corresponding to positions within ϳ308 nm of the plasmalemma were utilized to assess superficial SR content. The intensity of the DiOC 6 (For simplicity, data from the hyperlipidemic and diabetic dyslipidemic plus exercise-trained swine are not shown.) A and E: typical tracings of the responses to the experimental solutions S1-S4: S1 ϭ high K ϩ ϩ caffeine ϩ thapsigargin; S2 ϭ high K ϩ , low Na ϩ ϩ caffeine ϩ thapsigargin; S3 ϭ high K ϩ ϩ caffeine ϩ thapsigargin ϩ CBE; and S4 ϭ high K ϩ , low Na ϩ ϩ caffeine ϩ thapsigargin ϩ CBE. [Data from the experimental solution 80 mM K ϩ ϩ caffeine (SØ) is not shown for simplicity.] B and F: average data Ϯ SE for each of the experimental protocols is shown for the peak, 7-min, and 10-min responses. C and G: average slope Ϯ SE for the time range from the peak response to 7 min. D and H: average slope Ϯ SE for the time range from 7 to 10 min. Bottom: Ca 2ϩ -handling mechanisms that are active are denoted by the "ϩ," and the mechanisms that are inactive are denoted by the "Ϫ." SERCA, sarco(endo)plasmic reticulum Ca 2ϩ -ATPase; NCX, Na ϩ /Ca 2ϩ exchanger. * and **Statistically significant differences, P Ͻ 0.05, as explained in text.
fluorescence was normalized to the fluorescence of a 4-m multispectral bead (Fig. 3F, inset) that displayed a linear relationship between fluorescence intensity and exposure time to the 485-nm light (Fig. 3F) .
Effects Of Diabetes And Exercise Training
Diabetic dyslipidemia and exercise training. Table 1 summarizes the in vivo data for the indicators of diabetic dyslipidemia and exercise training. The percent changes in body weight from week 0 to week 19 were significantly elevated in the hyperlipidemic, diabetic dyslipidemic, and exercise-trained diabetic dyslipidemic swine above control. This was expected because all animals fed the high-fat, high-cholesterol diet were maintained utilizing feed and insulin algorithms to elicit a 3% gain in body weight per week. Fasting plasma glucose levels were elevated ϳ3.5-fold in both the diabetic dyslipidemic and the diabetic dyslipidemic plus exercise-trained animals, indicative of alloxan-induced hyperglycemia. The glucose levels reported here are ϳ70 mg/dl greater than our laboratory's previous reports (16, 17, 41) because the blood was collected under anesthesia. There was no significant difference in the average daily insulin dosage between the diabetic dyslipidemic and exercise-trained swine. Postprandial lipid values for total cholesterol levels were two-to sixfold higher in the hyperlipidemic, diabetic dyslipidemic, and diabetic dyslipidemic plus exercise-trained animals over control. Total triglycerides were only increased in diabetic dyslipidemic and diabetic dyslipidemic plus exercise-trained groups, thus the term "diabetic dyslipidemic," because hypertriglyceridemia is a hallmark of lipid abnormalities in diabetes (27) . In contrast, nondiabetic pigs fed the high-fat and high-cholesterol diet are defined as "hyperlipidemic." Similarly, fasting cholesterol levels were six-to eightfold higher in the hyperlipidemic, diabetic dyslipidemic, and diabetic dyslipidemic plus exercise-trained swine over control. There was no significant difference in fasting total triglyceride levels. Efficacy of the exercise training protocol was verified by a decrease in the resting heart rate at week 20 from 75 beats/min in the diabetic dyslipidemic animals to 58 beats/min in the exercise-trained diabetic dyslipidemic animals, decreased heart rate during submaximal exercise, and increased physical work capacity (4) .
Basal intracellular Ca 2ϩ levels are elevated in hyperlipidemia and diabetic dyslipidemia. Basal intracellular Ca 2ϩ levels were assessed as the fura-2 emission before any experimental perturbation. As shown in Fig. 4 , the basal Ca 2ϩ levels were significantly increased in cells from both the hyperlipidemic and diabetic dyslipidemic swine above control. In this study, exercise training concurrent with diabetic dyslipidemia did not significantly lower the basal intracellular Ca 2ϩ levels below control. The Ca 2ϩ level intermediate between control and diabetic dyslipidemic, however, indicated that exercise did not prevent, but attenuated, the effects of diabetic dyslipidemia.
Assessment of steady-state intracellular Ca 2ϩ levels with fura red. The effect(s) of hyperlipidemia, diabetic dyslipidemia, and diabetic dyslipidemia plus exercise training on steady-state intracellular Ca 2ϩ regulation was assessed by using the indicator fura red. The steady-state change in the fura red ratio from the preexperimental solution start point to the end of the response was used to assess the relative contribution of the Ca 2ϩ transporters to the maintenance of steady-state intracellular Ca 2ϩ levels. In healthy cells from control swine, steady-state intracellular Ca 2ϩ levels were not elevated until both the SERCA and the PMCA were simultaneously inhibited (S3 and S4) (Fig. 5A) . Direct inhibition of SERCA alone (S1), or in combination with the NCX (S2), resulted in no significant increase in the steady-state change above the application of 80 mM K ϩ plus caffeine alone (SØ). In cells from hyperlipidemic swine, there was an impaired ability to maintain steady-state intracellular Ca 2ϩ levels with the inhibition of the SERCA and either the NCX and/or the PMCA (S2, S3, and S4) (Fig. 5B) . This impairment in the maintenance of intracellular Ca 2ϩ levels above the 80KϩCafϩTG steady-state change (S1) suggested that the PMCA was impaired in the cells from the hyperlipidemic swine. In diabetic dyslipidemia, there was no significant change on exposure to any of the inhibitors (S1, S2, S3, and S4). This striking finding demonstrated that both the NCX and the PMCA were impaired with diabetic dyslipidemia and suggested that impaired plasmalemmal Ca 2ϩ extrusion may contribute to the elevated basal intracellular Ca 2ϩ levels in the diabetic dyslipidemic state (Fig. 5C ). Exercise training restored some intracellular Ca 2ϩ regulatory activity to the cells from the exercise-trained, diabetic dyslipidemic swine. In cells isolated from diabetic dyslipidemic plus exercise-trained swine, only the simultaneous inhibition of the SERCA, the NCX, and the PMCA (S4) resulted in a significant increase in the steady-state change response above SØ (Fig. 5D ). Considering that the diabetic dyslipidemic group exhibited a complete loss of intracellular Ca 2ϩ regulation via the SERCA, the NCX, and the PMCA, these results suggested that exercise training attenuated the loss of plasmalemmal Ca 2ϩ extrusion. Exercise prevented the diabetic dyslipidemia-induced decrease in superficial SR. The amount of superficial SR was quantified to assess the effect of hyperlipidemia, diabetic dyslipidemia, and exercise training concurrent with diabetic dyslipidemia on the structure of the superficial buffer barrier. The superficial SR was defined as the amount of DiOC 6 fluorescence within ϳ154 or ϳ308 nm of the plasmalemmal. As shown in Fig. 6A , the ratio of the cell layer (average DiOC 6 intensity per area) to the 4-m multispectral bead (average fluorescence per area) within ϳ154 nm of the plasmalemmal was not significantly altered between the treatment groups (P ϭ 0.067). However, as shown in Fig. 6B , the ratio of the cell layer (average DiOC 6 intensity per area) to the 4-m multispectral bead (average fluorescence per area) within ϳ308 nm of the plasmalemma was significantly (P Ͻ 0.05) decreased in cells from the hyperlipidemic and diabetic dyslipidemic swine. Exercise training concurrent with diabetic dyslipidemia prevented this decrease.
DISCUSSION
The major findings from these studies support the overall hypotheses that exercise training would attenuate and/or prevent the diabetic dyslipidemia-induced impairment in intracellular Ca 2ϩ regulation and the alteration in superficial SR content in coronary smooth muscle cells from diabetic dyslipidemic swine. Using freshly isolated cells loaded with the Ca 2ϩ indicator fura red, we found more specifically that plasmalemmal Ca 2ϩ extrusion was impaired in diabetic dyslipidemic Values are means Ϯ SE; n, no. of animals. Data are for control (C), hyperlipidemic (H), diabetic dyslipidemic (DD), and diabetic dyslipidemic plus exercise-trained (DDX) swine. N/A, not applicable. Yucatan swine and that exercise attenuated this impairment. These novel findings on the effects of exercise training are a significant extension of studies on Ca 2ϩ regulation in vascular smooth muscle of human uterine artery (10) , in vitro studies mimicking diabetes (33, 43) , and coronary artery studies from sedentary animals (16, 41) . Also, using freshly isolated cells loaded with the internal membrane dye, DiOC 6 , we found that the amount of superficial SR within ϳ308 nm of the plasmalemma is decreased with diabetic dyslipidemia and that exercise prevented this decrease. This novel finding suggested that the diabetic dyslipidemia-induced impairment in coronary smooth muscle intracellular Ca 2ϩ regulation may be linked to changes in the localization of the superficial SR.
The relative contribution of the NCX and the PMCA to the maintenance of steady-state intracellular Ca 2ϩ levels was assessed by direct inhibition with a low-Na ϩ -concentration perfusate and the fluorescein derivative, CBE, respectively. Although the SERCA was directly inhibited with TG, the activity of the SERCA was not isolated in these experiments. The reason for this omission in the experimental protocols was due to the ability of CBE to bind to constituents on the SR (i.e., SERCA) (Fig. 1, C and E) . A number of previous studies had utilized CBE as a specific and direct inhibitor of the PMCA while minimizing (3, 8) or neglecting (31) its possible effects on the SERCA. Using scanning laser confocal microscopy, we have clearly demonstrated that CBE is not solely localized to the PMCA in porcine coronary smooth muscle cells. The activity of the Na ϩ -K ϩ -ATPase was also not examined in these experiments, even though studies have demonstrated a diabetes-induced impairment in Na ϩ -K ϩ -ATPase activity in vascular smooth muscle (28, 32) . This was because both of the diabetic swine groups were given daily injections of exogenous insulin (see Table 1 ) to maintain targeted weight gain and plasma glucose levels throughout the 20-wk study. Administration of insulin in doses that do not fully normalize blood glucose prevents the diabetes-induced reduction in Na ϩ -K ϩ -ATPase activity (28, 32) . Although our study design involving insulin treatment is likely to have prevented impairment in Na ϩ -K ϩ -ATPase activity, we cannot conclude definitively without having directly measured Na ϩ -K ϩ -ATPase or the use of oubain in our Ca 2ϩ regulation studies.
In this study, exercise training attenuated, but did not prevent, the diabetic dyslipidemia-induced increase in basal intracellular Ca 2ϩ levels as we found in a preliminary study (44) . Although results demonstrating the efficacy of the exercise training protocol (i.e., decreased resting heart rates) were similar to those in a previous study (40) , there were no significant alterations in the fasting plasma lipid profile with exercise. Thus the lack of a significant decrease in the basal intracellular Ca 2ϩ levels in the cells from the diabetic dyslipidemic plus exercise-trained swine, together with the lack of a significant change in fasting plasma cholesterol and triglyceride values, suggested that the additional weight gain in this study hindered at least some of the beneficial effects of the exercise training bout. The absence of exercise training-induced attenuation of plasma lipids and glucose is very intriguing in that it strongly argues for either a more direct action of exercise on the vasculature or changes in other systemic (humoral factors) that might elicit the restoration in Ca 2ϩ extrusion and superficial SR distribution. Such direct vascular actions of exercise may be analogous to vascular actions of pharmacological agents, such as statins, which prevent coronary atherosclerosis and Ca 2ϩ signaling with no change in plasma cholesterol or glucose (23, 41) .
The cells from the diabetic dyslipidemic swine displayed a lack of response to any and/or all of the Ca 2ϩ -transporter inhibitors, suggesting that none of these transporters was functioning to maintain steady-state intracellular Ca 2ϩ levels. In other words, all Ca 2ϩ efflux mechanisms were already impaired in diabetic dyslipidemia and maximum concentrations of inhibitors did not further decrease Ca 2ϩ efflux. This lack of a response was consistent with other studies performed in coronary smooth muscle from diabetic dyslipidemic swine (26) and suggested that at least one of several alternative intracellular Ca 2ϩ regulatory mechanisms was compensating to buffer intracellular Ca 2ϩ levels to prevent further increases in Ca 2ϩ levels. These possible alternative mechanisms include intracellular Ca 2ϩ buffering via 1) the nuclear Ca 2ϩ store, 2) soluble intracellular Ca 2ϩ -binding proteins, and/or 3) the mitochondria. First, although a number of studies have shown that Ca 2ϩ is regulated differentially between the nucleus and the bulk myoplasm due to perinuclear Ca 2ϩ uptake (19, 41) , several studies have demonstrated a concentration-dependent loss in nuclear Ca 2ϩ reloading in response to the SERCA inhibitor, thapsigargin (1, 20) . Thus, even if SERCA-like pumps are found on the outer nuclear envelope, the use of TG in our experimental protocols would have inhibited this uptake. Second, the myoplasm of a coronary smooth muscle cell is rich with a number of soluble Ca 2ϩ -binding proteins, including calmodulin. Although diabetic rats showed decreased calmodulin levels (29) , the Ca 2ϩ -buffering capacity of calmodulin was not studied, nor have any studies assessed this possible perturbation in coronary smooth muscle cells. Third, the mitochondria have long been thought to contribute to intracellular Ca 2ϩ regulation under pathophysiological conditions. The mitochondrial Ca 2ϩ uniporter has a Michaelis constant for Ca 2ϩ that enables substantial Ca 2ϩ uptake only when local Ca 2ϩ concentrations exceed ϳ5.0 M (37). Even though the basal intracellular Ca 2ϩ levels did not reach this concentration in the cells from the diabetic dyslipidemic swine, a number of studies have demonstrated that locally high levels of Ca 2ϩ can be reached via a close apposition of the mitochondria to the SR (30, 35) . Fig. 6 . Exercise prevented the diabetic dyslipidemia-induced decrease in superficial sarcoplasmic reticulum. The superficial SR was defined as the SR within ϳ154 nm (A) or ϳ308 nm (B) of the plasmalemma. The amount of superficial SR was quantified as the ratio of the DiOC6 fluorescence (within ϳ154 or 308 nm of the plasmalemma) per area of these cell layers to the fluorescence of the multispectral bead per bead area (ratio of cell to bead). A: ratio of cell to bead within ϳ154 nm approached, but did not reach, statistical difference between groups (P ϭ 0.067). B: ratio of cell to bead was significantly decreased (*P Ͻ 0.01) within ϳ308 nm in cells from the H (0.53 Ϯ 0.03, n ϭ 8/46) and DD swine (0.51 Ϯ 0.03, n ϭ 5/38) below C (0.65 Ϯ 0.05, n ϭ 5/29). In DDX swine (0.67 Ϯ 0.04, n ϭ 6/39), the decrease in the ratio of the cell to bead was prevented.
Our data favor mitochondria as the alternative intracellular Ca 2ϩ -buffering mechanism, but largely by exclusion of the other mechanisms. Future studies should involve direct measurement of mitochondrial Ca 2ϩ levels. In cells from hyperlipidemic and diabetic dyslipidemic swine, there was a significant decrease in the amount of superficial SR as defined as the average DiOC 6 fluorescence within ϳ308 nm of the plasmalemma (Fig. 6 ). These data suggested that the impaired Ca 2ϩ extrusion in chronic hyperlipidemia and diabetic dyslipidemia could be due to a decrease in the amount of superficial SR. Another provocative implication of this finding is that the functional superficial buffer barrier might extend beyond the rare junctional SR located Ͻ50 nm from the plasmalemma (11) . Precedence for functional effects of acute changes in superficial buffer barrier was shown by the loss of subplasmalemmal Ca 2ϩ localization by pharmacologically induced retraction of endoplasmic reticulum deep (several micrometers) into vascular endothelial cells (13) . Alternatively, the diabetic dyslipidemia-induced impairment in Ca 2ϩ extrusion and the rise in basal intracellular Ca 2ϩ levels could initiate the morphological changes that are characteristic of dedifferentiated coronary smooth muscle cells in coronary artery disease models (18) . All of our previous studies had addressed the functional alteration of the superficial buffer barrier, i.e., the effects on Ca 2ϩ regulation. This is the first study to directly determine whether the structure of the superficial buffer barrier is altered, which in turn influences function of the superficial buffer barrier. Van Breemen's (36) seminal findings that laid the groundwork for the superficial buffer barrier hypothesis 25 years ago included this structural component of the SR, but until the present study there was no direct evidence for alteration of the structure of superficial SR associated with functional alterations in superficial buffer barrier regulation of Ca 2ϩ . In other words, van Breemen proposed that the exquisite positioning of the SR in close proximity to the sarcolemma (superficial SR) facilitated the superficial buffer barrier function. Our significant finding of retraction of the superficial SR is a key feature of the mechanism for functional changes in the superficial buffer barrier. Our work on the structure of the superficial buffer barrier has filled a major gap in the superficial buffer barrier hypothesis. Further mechanistic studies involving biochemical steps in the retraction of the superficial SR in diabetic dyslipidemia and prevention by exercise is very likely to involve cytoskeletal protein regulation and so forth. On the basis of the important findings in this manuscript, future studies of these biochemical regulators of superficial SR retraction are warranted.
In this study, exercise training prevented the diabetic dyslipidemia-induced changes in superficial SR content. This finding is a significant extension of previous studies performed in our laboratory that demonstrated an exercise-induced prevention of morphological changes in organ-cultured, coronary smooth muscle cells treated with endothelin-1 (39) . However, on the basis of these findings, it is presently unclear whether exercise primarily acts to attenuate changes in intracellular structure, which then modulate intracellular Ca 2ϩ regulation. Time course studies showing that alterations in superficial SR precede (result in) impaired Ca 2ϩ homeostasis would provide more compelling evidence for a cause-and-effect relationship, in addition to the association noted in this study.
In conclusion, we have definitively shown that aerobic exercise training attenuated the impairment of plasmalemmal Ca 2ϩ extrusion from coronary smooth muscle in diabetic dyslipidemic swine. Furthermore, this functional impairment was associated with a decrease in the amount of superficial SR within ϳ308 nm of the plasmalemma, which was also prevented by exercise training.
